2024
Human antibodies in Mexico and Brazil neutralizing tick-borne flaviviruses
Cervantes Rincón T, Kapoor T, Keeffe J, Simonelli L, Hoffmann H, Agudelo M, Jurado A, Peace A, Lee Y, Gazumyan A, Guidetti F, Cantergiani J, Cena B, Bianchini F, Tamagnini E, Moro S, Svoboda P, Costa F, Reis M, Ko A, Fallon B, Avila-Rios S, Reyes-Téran G, Rice C, Nussenzweig M, Bjorkman P, Ruzek D, Varani L, MacDonald M, Robbiani D. Human antibodies in Mexico and Brazil neutralizing tick-borne flaviviruses. Cell Reports 2024, 43: 114298. PMID: 38819991, DOI: 10.1016/j.celrep.2024.114298.Peer-Reviewed Original ResearchPowassan virusEnvelope domain IIIYellow fever virusZika virusFever virusSerological neutralizing activityTemperate regionsDengue virusTicksTropical areasInfect humansLineage IMosquito-borne flavivirusNeutralizing activityHuman antibodiesVirusNeurological illnessBrazilFlavivirusesP002P003Human diseases
2020
Changes in the dynamics of dengue incidence in South and Central America are possibly due to cross‐population immunity after Zika virus epidemics
Mugabe V, Borja L, Cardoso C, Weaver S, Reis M, Kitron U, Ribeiro G. Changes in the dynamics of dengue incidence in South and Central America are possibly due to cross‐population immunity after Zika virus epidemics. Tropical Medicine And International Health 2020, 26: 272-280. PMID: 33190402, DOI: 10.1111/tmi.13526.Peer-Reviewed Original ResearchConceptsDengue casesLaboratory-confirmed dengue casesDENV vaccine developmentSignificant public health implicationsDengue virus infectionDengue incidenceLong-term surveillance studyCross-species immunityPublic health implicationsIncidence of dengueVirus immunityVirus infectionEpidemiological dataSurveillance studyDengue feverZika virusDisease severityVaccine developmentIncidenceZika epidemicAnnual dengue incidenceZika outbreakHealth implicationsImmunityOverall rate
2019
Evaluation of two commercially available chikungunya virus IgM enzyme-linked immunoassays (ELISA) in a setting of concomitant transmission of chikungunya, dengue and Zika viruses
Kikuti M, Tauro L, Moreira P, Nascimento L, Portilho M, Soares G, Weaver S, Reis M, Kitron U, Ribeiro G. Evaluation of two commercially available chikungunya virus IgM enzyme-linked immunoassays (ELISA) in a setting of concomitant transmission of chikungunya, dengue and Zika viruses. International Journal Of Infectious Diseases 2019, 91: 38-43. PMID: 31704226, DOI: 10.1016/j.ijid.2019.11.001.Peer-Reviewed Original ResearchConceptsConvalescent samplesIgM enzymeRT-PCRZika virus transmissionNegative patientsCHIKV infectionAcute samplesZIKV casesConvalescent seraSurveillance studyCHIKV transmissionZika virusCHIKV casesDiagnostic performanceLow specificityVirus transmissionEquivocal resultsTest sensitivitySerumELISA specificityPatientsHigh rateDengueConcomitant transmissionMore equivocal results